Different GLP-1 therapies could be tailored to patients' individual metabolic needs

Дата публикации: 27-07-2026 20:20:08

Different varieties and doses of GLP-1 medications can have meaningful differences in how they address heart and metabolic health issues, according to new research led by the Perelman School of Medicine at the University of Pennsylvania. Through an analysis of data from 19 randomized controlled trials, the researchers believe their work points to possible precision medicine applications of GLP-1s beyond weight loss. Their work is published in Diabetes, Obesity, and Metabolism.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	GLP-1 drugs could become personalized for individuals, study says	0	14.17	31-07-2026
2	GLP-1s may improve outcomes in patients with PAD, diabetes	5	7	08-07-2026
3	Expert: GLP-1 therapies for obesity	0	9.13	03-12-2025
4	Ohio study finds GLP-1s are reshaping restaurant habits, with users spending less	0	5.45	24-07-2026
5	Traitements anti-obésité: les plus efficaces ont le plus d'effets secondaires	0	7	09-07-2026
6	Hope for new low cost slimming pill as daily tablet beats oral semaglutide in trial	0	7.86	26-02-2026
7	Number of Americans taking GLP-1s for weight loss hits record high: Survey	0	7	07-07-2026
8	If A GLP-1 Medication Has Changed Your Life For The Better, We Want To Hear About It	0	5	10-07-2026
9	Women more often hired after losing weight on GLP-1s: Study	0.2	0.6	03-07-2026
10	Weight loss drugs may literally be saving people's arms and legs	5	7	06-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.25. Источник: medicalxpress.com.